ArticleFrontiers in immunology2026
Identification of MTURN as a trained immunity-related biomarker for heart failure
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is a global health burden marked by high morbidity and limited treatment efficacy across subtypes. The lack of reliable molecular biomarkers for heart failure impedes personalized therapy. Emerging evidence suggests that macrophage-trained immunity drives chronic inflammation and cardiac remodeling, highlighting immune-related genes as promising biomarkers. Methods: We integrated transcriptomic data from five independent HF cohorts and one macrophage-trained immunity model. Differentially expressed genes (DEGs) analysis, weighted gene co-expression network analysis (WGCNA), immune infiltration profiling, and six machine-learning algorithms were applied to screen immune-related candidate genes. Functional relevance was assessed by gene set enrichment analysis (GSEA) and single-cell RNA-seq of human cardiac tissue. Finally, we established a THP-1-derived macrophage trained immunity model to validate the paracrine effects of macrophage Maturin (MTURN) and Piezo-type mechanosensitive ion channel component 1 (PIEZO1) in cardiomyocytes. Results: Seven hub genes were identified from HF-DEGs, the trained immunity transcriptional signature, and WGCNA co-expression modules. Among them, MTURN, an evolutionarily conserved regulator of differentiation and inflammation, emerged as the most robust candidate, showing consistent upregulation in HF samples across all cohorts with superior diagnostic performance. Importantly, GSEA linked MTURN to innate immune activation and adhesion/signaling pathways. Single-cell RNA-seq analyses of human cardiac tissue revealed MTURN enrichment in cardiac macrophages with a progressive increase along pseudotime. Experimentally, trained immunity macrophages displayed an elevation of glycolytic and inflammatory markers together with increased MTURN and PIEZO1. Accordingly, the conditioned medium collected from such trained macrophages could upregulate expression of HF markers ( Conclusion: Multi-cohort, single-cell RNA-seq, and experimental data collectively suggest MTURN as a trained immunity-related biomarker for the diagnosis of heart failure with a potential link to PIEZO1-mediated cardiac remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.